Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells
Open Access
- 18 December 2008
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 6 (1) , 80
- https://doi.org/10.1186/1479-5876-6-80
Abstract
Effective transvascular delivery of nanoparticle-based chemotherapeutics across the blood-brain tumor barrier of malignant gliomas remains a challenge. This is due to our limited understanding of nanoparticle properties in relation to the physiologic size of pores within the blood-brain tumor barrier. Polyamidoamine dendrimers are particularly small multigenerational nanoparticles with uniform sizes within each generation. Dendrimer sizes increase by only 1 to 2 nm with each successive generation. Using functionalized polyamidoamine dendrimer generations 1 through 8, we investigated how nanoparticle size influences particle accumulation within malignant glioma cells.Keywords
This publication has 74 references indexed in Scilit:
- Quantitative STEM and EFTEM Characterization of Dendrimer-Based Nanoparticles Used in Magnetic Resonance Imaging and Drug DeliveryMicroscopy and Microanalysis, 2008
- Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugsNature Clinical Practice Oncology, 2008
- Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranesProceedings of the National Academy of Sciences, 2007
- Cell Penetrating Peptides: How Do They Do It?Journal of Biological Physics, 2007
- Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumorsBiomaterials, 2007
- Renal clearance of quantum dotsNature Biotechnology, 2007
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- AFNI: Software for Analysis and Visualization of Functional Magnetic Resonance NeuroimagesComputers and Biomedical Research, 1996
- The RG2 rat glioma modelJournal of Neuro-Oncology, 1995
- Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after SurgeryNew England Journal of Medicine, 1980